You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Dow
McKesson
Baxter
Boehringer Ingelheim

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Patent: 7,897,585

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,897,585
Title:Nanoparticles for protein drug delivery
Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one anti-hemophilic factor or bioactive agent characterized with a positive surface charge and their enhanced permeability in oral drug delivery.
Inventor(s): Sung; Hsing-Wen (Hsinchu, TW), Tu; Hosheng (Newport Beach, CA)
Assignee: GP Medical, Inc. (Newport Beach, CA) National Tsing Hua University (Hsinchu, TW)
Application Number:12/378,976
Patent Claims:see list of patent claims

Details for Patent 7,897,585

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Kedrion Biopharma, Inc. KOATE antihemophilic factor (human) KIT 101130 1 1999-05-20   Start Trial GP Medical, Inc. (Newport Beach, CA) National Tsing Hua University (Hsinchu, TW) 2025-01-04 search
Baxalta Us Inc. HEMOFIL M antihemophilic factor human KIT 101448 1 1988-02-23   Start Trial GP Medical, Inc. (Newport Beach, CA) National Tsing Hua University (Hsinchu, TW) 2025-01-04 search
Grifols Usa, Llc ALPHANATE antihemophilic factor/von willebrand factor complex (human) KIT 102475 1 2014-06-26   Start Trial GP Medical, Inc. (Newport Beach, CA) National Tsing Hua University (Hsinchu, TW) 2025-01-04 search
Baxalta Us Inc. RECOMBINATE antihemophilic factor recombinant KIT 103375 1 2010-03-15   Start Trial GP Medical, Inc. (Newport Beach, CA) National Tsing Hua University (Hsinchu, TW) 2025-01-04 search
Csl Behring Llc MONOCLATE-P antihemophilic factor human KIT 103953 1 1990-05-30   Start Trial GP Medical, Inc. (Newport Beach, CA) National Tsing Hua University (Hsinchu, TW) 2025-01-04 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Colorcon
Harvard Business School
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.